Therefore, inhibiting the interaction between PD-L1 or PD-1 can restore the activity of T cells and enhance the immune killing effect on tumor cells (Herbst et al., 2014; Sunshine and Taube, 2105). The gene discussed is CD274; the disease is neoplasm.